首页>
外国专利>
S100A8/S100A9-INDUCED IMMUNOTOLERANCE IN NEWBORN SUBJECTS
S100A8/S100A9-INDUCED IMMUNOTOLERANCE IN NEWBORN SUBJECTS
展开▼
机译:S100A8 / S100A9在新生受试者中引起的免疫耐受
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present application provides for the use of S100A8 or S100A9 homodimer or S100A8/A9 heterodimer in the prevention or treatment of a NF-κB-associated postnatal inflammatory disorder in a newborn subject. Moreover, the present invention relates to a pharmaceutical composition comprising S100A8 or S100A9 homodimer or S100A8/A9 heterodimer and an in vitro method for evaluating the risk of a newborn subjectfor developing a NF-κB-associated postnatal inflammatory disorder.
展开▼